Finance

Results: 6781-6792 of 48329

Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy

Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 - March 2027)

PR Newswire associated0

Plante Moran opens Amsterdam office as part of ongoing international expansion

PR Newswire associated0

Ozelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis

Democracy's super-charged approach scoops a mighty fine nine PRCA award nominations

Skanska does construction work for an unnamed customer for about SEK 1.9 billion

PR Newswire associated0

China Pavilion at the 61st International Art Exhibition - La Biennale di Venezia: Dream Stream

PR Newswire associated0

Arabic edition of Volume I of "China's Governance Under Xi Jinping's Leadership" launched in Cairo

PR Newswire associated0

Natalia Dyer Named Global Muse for Purito Seoul

Business Wire logo

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet

PR Newswire associated0

Hormuz crisis shows clean energy is key to reducing the economic cost of fossil fuel dependence

PR Newswire associated0

/C O R R E C T I O N -- Advita Ortho, LLC/